Cargando…

Cryotherapy after Topical Interferon Alpha 2b to Treat Conjunctival Primary Acquired Melanosis

When primary acquired melanosis (PAM) with atypia affects the tarsal conjunctiva, a radical surgery can be mutilating, requiring reconstructive surgery of the eyelid. Topical chemotherapy associated to local cryotherapy may be an alternative. A 64-year-old Caucasian female presented with diffuse PAM...

Descripción completa

Detalles Bibliográficos
Autores principales: Huerva, Valentín, Vilardell, Felip, Cid-Bertomeu, Pau
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035544/
https://www.ncbi.nlm.nih.gov/pubmed/36968810
http://dx.doi.org/10.1159/000529667
_version_ 1784911434996514816
author Huerva, Valentín
Vilardell, Felip
Cid-Bertomeu, Pau
author_facet Huerva, Valentín
Vilardell, Felip
Cid-Bertomeu, Pau
author_sort Huerva, Valentín
collection PubMed
description When primary acquired melanosis (PAM) with atypia affects the tarsal conjunctiva, a radical surgery can be mutilating, requiring reconstructive surgery of the eyelid. Topical chemotherapy associated to local cryotherapy may be an alternative. A 64-year-old Caucasian female presented with diffuse PAM of the right eye involving the inferior tarsal conjunctiva, fornix, and inferotemporal bulbar conjunctiva. Histological study showed a PAM with atypia (C-MIN 5). Given the extent of the lesion and its location, a wide mutilating excision was ruled out. Topical interferon alpha 2b (IFN-α2b) treatment (1,000,000 IU/mL, 4 times a day) was administered during 10 weeks. However, the regression was very slow. Then local cryotherapy was proposed (8 s at −80°C per application) to the entire pigmented lesion. This afforded progressive depigmentation, which was completed 2 months later. No recurrence of the lesion has been noted during 3 years of follow-up. The combination of the two procedures reduces IFN-α2b eyedrop administration time, enhancing patient compliance. The combination may eradicate the tumor without compromising ocular cosmesis.
format Online
Article
Text
id pubmed-10035544
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-100355442023-03-24 Cryotherapy after Topical Interferon Alpha 2b to Treat Conjunctival Primary Acquired Melanosis Huerva, Valentín Vilardell, Felip Cid-Bertomeu, Pau Case Rep Ophthalmol Case Report When primary acquired melanosis (PAM) with atypia affects the tarsal conjunctiva, a radical surgery can be mutilating, requiring reconstructive surgery of the eyelid. Topical chemotherapy associated to local cryotherapy may be an alternative. A 64-year-old Caucasian female presented with diffuse PAM of the right eye involving the inferior tarsal conjunctiva, fornix, and inferotemporal bulbar conjunctiva. Histological study showed a PAM with atypia (C-MIN 5). Given the extent of the lesion and its location, a wide mutilating excision was ruled out. Topical interferon alpha 2b (IFN-α2b) treatment (1,000,000 IU/mL, 4 times a day) was administered during 10 weeks. However, the regression was very slow. Then local cryotherapy was proposed (8 s at −80°C per application) to the entire pigmented lesion. This afforded progressive depigmentation, which was completed 2 months later. No recurrence of the lesion has been noted during 3 years of follow-up. The combination of the two procedures reduces IFN-α2b eyedrop administration time, enhancing patient compliance. The combination may eradicate the tumor without compromising ocular cosmesis. S. Karger AG 2023-03-22 /pmc/articles/PMC10035544/ /pubmed/36968810 http://dx.doi.org/10.1159/000529667 Text en © 2023 The Author(s). Published by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Case Report
Huerva, Valentín
Vilardell, Felip
Cid-Bertomeu, Pau
Cryotherapy after Topical Interferon Alpha 2b to Treat Conjunctival Primary Acquired Melanosis
title Cryotherapy after Topical Interferon Alpha 2b to Treat Conjunctival Primary Acquired Melanosis
title_full Cryotherapy after Topical Interferon Alpha 2b to Treat Conjunctival Primary Acquired Melanosis
title_fullStr Cryotherapy after Topical Interferon Alpha 2b to Treat Conjunctival Primary Acquired Melanosis
title_full_unstemmed Cryotherapy after Topical Interferon Alpha 2b to Treat Conjunctival Primary Acquired Melanosis
title_short Cryotherapy after Topical Interferon Alpha 2b to Treat Conjunctival Primary Acquired Melanosis
title_sort cryotherapy after topical interferon alpha 2b to treat conjunctival primary acquired melanosis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035544/
https://www.ncbi.nlm.nih.gov/pubmed/36968810
http://dx.doi.org/10.1159/000529667
work_keys_str_mv AT huervavalentin cryotherapyaftertopicalinterferonalpha2btotreatconjunctivalprimaryacquiredmelanosis
AT vilardellfelip cryotherapyaftertopicalinterferonalpha2btotreatconjunctivalprimaryacquiredmelanosis
AT cidbertomeupau cryotherapyaftertopicalinterferonalpha2btotreatconjunctivalprimaryacquiredmelanosis